Skip to search formSkip to main contentSkip to account menu

Quality of Life Questionnaire - Gastrointestinal Neuroendocrine Tumors 21

Known as: EORTC QLQ-GINET21, QLQ-G.I.NET21 
A questionnaire intended for use among patients with gastrointestinal-related neuroendocrine tumors, who vary in disease stage and treatments.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Introduction Liver Function Tests (LFTs) are frequently checked in primary care although liver disease is not suspected in the… 
2016
2016
Introduction Treatments available to patients with neuroendocrine tumours(NETs) have been studied for their effect on tumour… 
2010
2010
Objective To study the effects of uncertainty in illness on cancer-related fatigue and scores of Quality of Life Questionnaire of… 
Review
2000
Review
2000
In order to evaluate the efficacy of cancer therapy, it is important to assess quality of life (QOL) as an endpoint in addition…